Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 5/2006

01-10-2006

Pulmonary Hemosiderosis in Association with Celiac Disease

Authors: Nevin Taci Hoca, Didem Dayioglu, Mihriban Ogretensoy

Published in: Lung | Issue 5/2006

Login to get access

Abstract

A 15-year-old male had a history of increasing dyspnea on exertion, cough, sputum production, fever, weakness, hemoptysis, and diarrhea. Chest radiography demonstrated bilateral alveolar consolidation. Bronchoalveolar lavage fluid analysis revealed extensive hemosiderin-laden alveolar macrophages. On the basis of iron deficiency anemia, diarrhea, raised antigliadin and antiendomysial antibodies, widespread villous atrophy, and crypt hyperplasia on intestinal biopsy, celiac disease was diagnosed. After treatment with a gluten-free diet, all his clinical symptoms and radiographic findings improved within two weeks.
Literature
1.
Bouros D, Panagou P, Rokkas T, Siafakas NM (1994) Bronchoalveolar lavage findings in a young adult with idiopathic pulmonary haemosiderosis and celiac disease. Eur Respir J 7:1009–1012PubMed
2.
Edwards C, Williams A, Asoquith P (1985) Bronchopulmonary disease in celiac patients. J Clin Pathol 38:361–367PubMed
3.
Gold WM (2000) Pulmonary function testing. In: Murray JF, Nadel JA (eds) Textbook of Respiratory Medicine, vol 1. Saunders, Philadelphia, pp 781–881
4.
Hartl D, Belohradsky BH, Griese M, et al. (2004) Celiac disease and pulmonary hemosiderosis in a patient with chronic granulomatous disease. Pediatr Pulmonol 38:344–348PubMedCrossRef
5.
Kelly J, O’Farrely C, Rees JPR, Feighery C, Weir DGW (1987) Humoral response to alpha-gliadin as serological screening test for celiac disease. Arch Dis Child 62:469–473PubMed
6.
Ludmerer KM, Kissane JM (1986) Hemoptysis, pulmonary infiltrates, and diarrhea in a 36-year-old man: clinicopathologic conference. Am J Med 80:930–938CrossRef
7.
Mahadeva R, Flower C, Shneerson J (1998) Bronchiectasis in association with celiac disease. Thorax 53:527–529PubMedCrossRef
8.
Malhotra P, Aggarwal R, Aggarwal AN, et al. (2005) Celiac disease as a cause of unusually severe anemia in a young man with idiopathic pulmonary haemosiderosis. Respir Med 99(4):451–453PubMedCrossRef
9.
Pacheco A, Casanova C, Fogue L, Sueiro A (1991) Long-term clinical follow-up of adult idiopathic pulmonary haemosiderosis and celiac disease. Chest 99(6):1525–1526PubMed
10.
Perelman S, Dupuy C, Bourrillon A (1992) The Association of pulmonary hemosiderosis and celiac disease. Apropos of a new case in a child. Ann Pediatr (Paris) 39(3):185–188 (abstr)
11.
Ploier R, Emhofer J, Dorninger L, et al. (1998) Immunological aspects of a child with idiopathic pulmonary hemosiderosis and celiac disease. Klin Padiatr 210(6):409–412PubMedCrossRef
12.
Reading R, Watson JG, Platt JW, Bird AG (1987) Pulmonary haemosiderosis and gluten. Arch Dis Child 62:513–515PubMed
13.
Schwarz MI (1998) Diffiise alveolar hemorrhage. In: Schwarz MI, King TI (eds) Interstitial Lung Disease. B.C. Decker Inc., Hamilton- London, pp 535–558
14.
Schwarz MI, Cherniack RM, King TE (2000) Diffuse alveolar hemorrhage and other rare infiltrative disorders. In: Murray JF, Nadel JA (eds) Textbook of Respiratory Medicine, vol 2. Saunders, Philadelphia, pp 1733–l755
Metadata
Title
Pulmonary Hemosiderosis in Association with Celiac Disease
Authors
Nevin Taci Hoca
Didem Dayioglu
Mihriban Ogretensoy
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Lung / Issue 5/2006
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-005-2596-6

Other articles of this Issue 5/2006

Lung 5/2006 Go to the issue

STATE OF THE ART REVIEW

Perception of Airway Obstruction and Airway Inflammation in Asthma: A Review

LUNG CANCER

The Role of c-erbB-2 Expression on the Survival of Patients with Small-Cell Lung Cancer

INTERSTITIAL LUNG DISEASE

Green Tea Extract Inhibits Paraquat-Induced Pulmonary Fibrosis by Suppression of Oxidative Stress and Endothelin-l Expression

OriginalPaper

Achieving Full-Dose, On-Schedule Administration of ACE Chemotherapy Every 14 Days for the Treatment of Patients with Extensive Small-Cell Lung Cancer

PULMONARY VASCULAR ENDOTHELIUM

Release of Soluble E-Selectin from Activated Endothelial Cells upon Apoptosis

OriginalPaper

Clinical Characteristics of a Second Small Nodule(s) Associated with cT1–2N0M0 Non-Small-Cell Lung Cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits